Quality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapy
- PMID: 34046100
- PMCID: PMC8139742
- DOI: 10.14740/wjon1371
Quality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapy
Abstract
Background: Patients with lung cancer often experience multiple symptoms associated with both the disease itself and the treatment. The disease and therapy-related adverse effects may lead to poor quality of life (QoL) and increased psychological distress. The aim of this study was to investigate the QoL and psychological distress of patients with lung cancer. The relationship between these two aspects was also an area of focus.
Methods: This was a quantitative descriptive study. Data collection was done using a self-complementary tool. The data were collected between February and March 2020. The sample consisted of 135 patients with lung cancer who were undergoing chemotherapy in 1-day clinic in Athens (a sample of convenience).
Results: Regarding the QoL of our sample, we observed that the mean score of the physical health component of SF-12 was 38.17 ± 9.94 and of the mental health component was 45.63 ± 11.80. As regards the psychological distress of our sample, we observed that the mean score for depression was 4.55 ± 5.04, for anxiety was 3.84 ± 4.17 and for stress was 5.21 ± 5.01.
Conclusion: As is clear from the results, lung cancer patients reported poor QoL and increased rates of psychological distress.
Keywords: Chemotherapy; Lung cancer; Psychological distress; Quality of life.
Copyright 2021, Prapa et al.
Conflict of interest statement
None to declare.
Similar articles
-
[Chemotherapy-related Cognitive Impairment and Quality of Life in People with Colon Cancer: The Mediating Effect of Psychological Distress].J Korean Acad Nurs. 2016 Feb;46(1):19-28. doi: 10.4040/jkan.2016.46.1.19. J Korean Acad Nurs. 2016. PMID: 26963411 Korean.
-
Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy.Eur J Oncol Nurs. 2010 Dec;14(5):400-9. doi: 10.1016/j.ejon.2010.01.003. Epub 2010 Feb 10. Eur J Oncol Nurs. 2010. PMID: 20149733
-
Assessment of sleep disturbance in lung cancer patients: relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress.Palliat Support Care. 2015 Jun;13(3):575-81. doi: 10.1017/S1478951513001119. Epub 2014 Feb 13. Palliat Support Care. 2015. PMID: 24524428
-
Quality of life and psychological distress during cancer: a prospective observational study involving young breast cancer female patients.BMC Cancer. 2020 Aug 13;20(1):758. doi: 10.1186/s12885-020-07272-8. BMC Cancer. 2020. PMID: 32791959 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
Cited by
-
A latent profile analysis of resilience and their relation to differences in sleep quality in patients with lung cancer.Support Care Cancer. 2024 Feb 13;32(3):155. doi: 10.1007/s00520-024-08337-1. Support Care Cancer. 2024. PMID: 38347229
-
Early Prediction of ABO HDN Using Immuno-Hematological and Biochemical Tests.Maedica (Bucur). 2024 Dec;19(4):711-717. doi: 10.26574/maedica.2024.19.4.711. Maedica (Bucur). 2024. PMID: 39974463 Free PMC article.
-
The Usefulness of Virtual Reality in Symptom Management during Chemotherapy in Lung Cancer Patients: A Quasi-Experimental Study.J Clin Med. 2024 Jul 26;13(15):4374. doi: 10.3390/jcm13154374. J Clin Med. 2024. PMID: 39124641 Free PMC article.
-
Anxiety and Depression in Non-Small Cell Lung Cancer Patients Receiving Chemotherapy Compared to Those Receiving Immunotherapy.Maedica (Bucur). 2024 Sep;19(3):453-460. doi: 10.26574/maedica.2024.19.3.453. Maedica (Bucur). 2024. PMID: 39553374 Free PMC article.
-
Systematic assessment of microRNAs associated with lung cancer and physical exercise.Front Oncol. 2022 Aug 30;12:917667. doi: 10.3389/fonc.2022.917667. eCollection 2022. Front Oncol. 2022. PMID: 36110941 Free PMC article.
References
-
- Kim R, Keam B, Hahn S, Ock CY, Kim M, Kim TM, Kim DW. et al. First-line pembrolizumab versus pembrolizumab plus chemotherapy versus chemotherapy alone in non-small-cell lung cancer: a systematic review and network meta-analysis. Clin Lung Cancer. 2019;20(5):331–338. doi: 10.1016/j.cllc.2019.05.009. e334. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials